Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone

被引：5
作者：
Leese, G
Jeffreys, R
Vora, J
机构：
[1] ROYAL LIVERPOOL UNIV HOSP,DEPT MED,LIVERPOOL,MERSEYSIDE,ENGLAND
[2] WALTON HOSP,DEPT NEUROSURG,LIVERPOOL L9 1AE,MERSEYSIDE,ENGLAND
来源：
POSTGRADUATE MEDICAL JOURNAL | 1997年 / 73卷 / 862期
关键词：
follicle-stimulating hormone; pituitary adenoma; cabergoline;
D O I：
10.1136/pgmj.73.862.507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A patient with a pituitary adenoma secreting follicle-stimulating hormone with coexistent primary hyperaldosteronism is described. After his second transsphenoidal surgery, the patient developed a Staphylococcus aureus pituitary abscess. Symptoms improved after abscess drainage. Subsequent cabergoline therapy arrested the deterioration of symptoms, and decreased serum follicle-stimulating hormone concentrations. Cabergoline may be a useful treatment for aggressively growing non-prolactin-secreting pituitary adenomas.
引用
收藏
页码：507 / 508
页数：2
相关论文
共 10 条
[1]   ACUTE EFFECTS OF PARLODEL-LAR AND RESPONSE TO LONG-TERM TREATMENT WITH BROMOCRIPTINE IN A PATIENT WITH A FOLLICLE-STIMULATING HORMONE-SECRETING PITUITARY-ADENOMA [J].
ABS, R ;
PARIZEL, PM ;
BECKERS, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (02) :135-138
[2]   CLINICAL AND PATHOLOGICAL EFFECTS OF BROMOCRIPTINE ON PROLACTIN-SECRETING AND OTHER PITUITARY-TUMORS [J].
BARROW, DL ;
TINDALL, GT ;
KOVACS, K ;
THORNER, MO ;
HORVATH, E ;
HOFFMAN, JC .
JOURNAL OF NEUROSURGERY, 1984, 60 (01) :1-7
[3]   REDUCTION OF FOLLICLE-STIMULATING-HORMONE (FSH) SECRETION IN FSH-PRODUCING PITUITARY-ADENOMA BY BROMOCRIPTINE [J].
BEREZIN, M ;
OLCHOVSKY, D ;
PINES, A ;
TADMOR, R ;
LUNENFELD, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (06) :1220-1223
[4]   NONFUNCTIONING PITUITARY-ADENOMAS DO NOT REGRESS DURING BROMOCRIPTINE THERAPY BUT POSSESS MEMBRANE-BOUND DOPAMINE-RECEPTORS WHICH BIND BROMOCRIPTINE [J].
BEVAN, JS ;
BURKE, CW .
CLINICAL ENDOCRINOLOGY, 1986, 25 (05) :561-572
[5]   THE EFFECT OF DOPAMINE AGONIST THERAPY ON LARGE FUNCTIONLESS PITUITARY-TUMORS [J].
GROSSMAN, A ;
ROSS, R ;
CHARLESWORTH, M ;
ADAMS, CBT ;
WASS, JAH ;
DONIACH, I ;
BESSER, GM .
CLINICAL ENDOCRINOLOGY, 1985, 22 (05) :679-686
[6]   LONG-TERM TREATMENT WITH THE DOPAMINE AGONIST CV-205-502 OF PATIENTS WITH A CLINICALLY NONFUNCTIONING, GONADOTROPH, OR ALPHA-SUBUNIT SECRETING PITUITARY-ADENOMA [J].
KWEKKEBOOM, DJ ;
LAMBERTS, SWJ .
CLINICAL ENDOCRINOLOGY, 1992, 36 (02) :171-176
[7]   MEDICAL-TREATMENT OF PITUITARY-ADENOMAS - EFFECTS ON TUMOR-GROWTH [J].
LIUZZI, A ;
CHIODINI, PG ;
DALLABONZANA, D ;
OPPIZZI, G ;
VERDE, GG .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1985, 8 (03) :273-281
[8]  
PAOLETTI AM, 1994, FERTIL STERIL, V62, P882
[9]   FOLLICLE-STIMULATING HORMONE-SUBUNIT AND ALPHA-SUBUNIT-SECRETING PITUITARY-TUMOR TREATED WITH BROMOCRIPTINE [J].
VANCE, ML ;
RIDGWAY, EC ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (03) :580-584
[10]  
VANSCHAARDENBURG D, 1989, CLIN ENDOCRINOL, V30, P475
1